Cargando…

Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients

BACKGROUND: Dioxins and dioxin-like compounds have half-lives typically between 7.2 years and 15 years. Our previous study of patients poisoned by extremely high concentrations of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in the ‘Yusho incident’ in 1968 found that in some the half-life of blood 2,3,...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Shinya, Akahane, Manabu, Kanagawa, Yoshiyuki, Kajiwara, Jumboku, Mitoma, Chikage, Uchi, Hiroshi, Furue, Masutaka, Imamura, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574225/
https://www.ncbi.nlm.nih.gov/pubmed/26384313
http://dx.doi.org/10.1186/s12940-015-0059-y
_version_ 1782390596953964544
author Matsumoto, Shinya
Akahane, Manabu
Kanagawa, Yoshiyuki
Kajiwara, Jumboku
Mitoma, Chikage
Uchi, Hiroshi
Furue, Masutaka
Imamura, Tomoaki
author_facet Matsumoto, Shinya
Akahane, Manabu
Kanagawa, Yoshiyuki
Kajiwara, Jumboku
Mitoma, Chikage
Uchi, Hiroshi
Furue, Masutaka
Imamura, Tomoaki
author_sort Matsumoto, Shinya
collection PubMed
description BACKGROUND: Dioxins and dioxin-like compounds have half-lives typically between 7.2 years and 15 years. Our previous study of patients poisoned by extremely high concentrations of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in the ‘Yusho incident’ in 1968 found that in some the half-life of blood 2,3,4,7,8-PeCDF tended towards infinity. This suggests that there are two groups of Yusho patients, those with 2,3,4,7,8-PeCDF half-lives around 10 years, and those with half-lives near infinity. We sought to establish the proportions of each in a cohort of 395 Yusho patients, and whether the proportions were changing over time. METHODS: We undertook longitudinal measurement of the blood concentration of 2,3,4,7,8-PeCDF in our cohort between 2002 and 2010. We estimated the change in concentration for each patient using linear regression for measured 2,3,4,7,8-PeCDF concentration, then compared the distribution of changes in concentrations with our previous study. RESULTS: In patients in whom the blood concentration of 2,3,4,7,8-PeCDF exceeded 50 pg/g lipid, the proportion 8.0 % of patients exhibiting half-lives less than 13.3 years fell compared with our previous study (28.2 %), while the proportion with near infinity half-lives increased. CONCLUSION: The prolongation of the half-lives was likely a consequence of age-related factors.
format Online
Article
Text
id pubmed-4574225
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45742252015-09-19 Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients Matsumoto, Shinya Akahane, Manabu Kanagawa, Yoshiyuki Kajiwara, Jumboku Mitoma, Chikage Uchi, Hiroshi Furue, Masutaka Imamura, Tomoaki Environ Health Research BACKGROUND: Dioxins and dioxin-like compounds have half-lives typically between 7.2 years and 15 years. Our previous study of patients poisoned by extremely high concentrations of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in the ‘Yusho incident’ in 1968 found that in some the half-life of blood 2,3,4,7,8-PeCDF tended towards infinity. This suggests that there are two groups of Yusho patients, those with 2,3,4,7,8-PeCDF half-lives around 10 years, and those with half-lives near infinity. We sought to establish the proportions of each in a cohort of 395 Yusho patients, and whether the proportions were changing over time. METHODS: We undertook longitudinal measurement of the blood concentration of 2,3,4,7,8-PeCDF in our cohort between 2002 and 2010. We estimated the change in concentration for each patient using linear regression for measured 2,3,4,7,8-PeCDF concentration, then compared the distribution of changes in concentrations with our previous study. RESULTS: In patients in whom the blood concentration of 2,3,4,7,8-PeCDF exceeded 50 pg/g lipid, the proportion 8.0 % of patients exhibiting half-lives less than 13.3 years fell compared with our previous study (28.2 %), while the proportion with near infinity half-lives increased. CONCLUSION: The prolongation of the half-lives was likely a consequence of age-related factors. BioMed Central 2015-09-17 /pmc/articles/PMC4574225/ /pubmed/26384313 http://dx.doi.org/10.1186/s12940-015-0059-y Text en © Matsumoto et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Matsumoto, Shinya
Akahane, Manabu
Kanagawa, Yoshiyuki
Kajiwara, Jumboku
Mitoma, Chikage
Uchi, Hiroshi
Furue, Masutaka
Imamura, Tomoaki
Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients
title Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients
title_full Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients
title_fullStr Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients
title_full_unstemmed Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients
title_short Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients
title_sort unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (pecdf) levels in yusho patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574225/
https://www.ncbi.nlm.nih.gov/pubmed/26384313
http://dx.doi.org/10.1186/s12940-015-0059-y
work_keys_str_mv AT matsumotoshinya unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients
AT akahanemanabu unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients
AT kanagawayoshiyuki unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients
AT kajiwarajumboku unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients
AT mitomachikage unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients
AT uchihiroshi unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients
AT furuemasutaka unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients
AT imamuratomoaki unexpectedlylonghalflivesofblood23478pentachlorodibenzofuranpecdflevelsinyushopatients